miRNA General Information
miRNA Mature ID hsa-miR-17-3p
miRNA Stemloop AC MI0000071
miRNA Stemloop ID hsa-mir-17
Sequence acugcagugaaggcacuuguag
TTD Target(s) Regulated by This miRNA Vascular endothelial growth factor receptor 2 (KDR) Successful Target Target Info [1]
Intercellular adhesion molecule ICAM-1 (ICAM1) Successful Target Target Info [2]
Integrin alpha-5 (ITGA5) Clinical trial Target Target Info [3]
E-selectin (SELE) Clinical trial Target Target Info [2]
Superoxide dismutase Mn (SOD Mn) Clinical trial Target Target Info [4]
Nuclear receptor coactivator 3 (NCOA3) Literature-reported Target Target Info [5]
Phosphatase and tensin homolog (PTEN) Literature-reported Target Target Info [6]
Integrin beta-3 (ITGB3) Literature-reported Target Target Info [3]
Protein(s) Regulated by This miRNA Glutathione peroxidase 2 Regulated Protein [4]
Metalloproteinase inhibitor 3 Regulated Protein [8]
Metalloproteinase inhibitor 3 Regulated Protein [9]
N-acetylgalactosaminyltransferase 7 Regulated Protein [10]
Thioredoxin reductase 2, mitochondrial Regulated Protein [4]
Vimentin Regulated Protein [11]
References
REF 1 MiR-17-3p inhibits angiogenesis by downregulating flk-1 in the cell growth signal pathway. J Vasc Res. 2013;50(2):157-66.
REF 2 Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010 Jan 1;184(1):21-5.
REF 3 miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1. Oncol Rep. 2016 Oct;36(4):2177-83.
REF 4 miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One. 2010 Dec 22;5(12):e14356.
REF 5 Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3. Cell Death Dis. 2016 Nov 10;7(11):e2463.
REF 6 Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget. 2015 Sep 29;6(29):27214-26.
REF 7 miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One. 2010 Dec 22;5(12):e14356.
REF 8 Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion.Nucleic Acids Res. 2013 Nov;41(21):9688-704.
REF 9 miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.Theranostics. 2017 Jan 15;7(3):664-676.
REF 10 Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci. 2013 Mar 15;126(Pt 6):1517-30.
REF 11 MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.Clin Exp Metastasis. 2009;26(8):965-79.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.